Pediatrix Medical Group Inc(MD) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 4:01 PM ET (Korea 9/12 05:01)
Full metrics table
| Index | RUT | P/E | 12.86 | EPS (ttm) | 2.08 | Insider Own | 1.58% | Shs Outstand | 81.2M | Perf Week | -0.41% |
| Market Cap | 2.18B | Forward P/E | 10.97 | EPS next Y | 3.91% | Insider Trans | -2.73% | Shs Float | 80.0M | Perf Month | 1.02% |
| Enterprise Value | 2.39B | PEG | 1.83 | EPS next Q | 0.65 | Inst Own | 104.35% | Short Float | 6.02% | Perf Quarter | 10.8% |
| Income | 0.17B | P/S | 1.12 | EPS this Y | 15.09% | Inst Trans | 0.46% | Short Ratio | 6.06 | Perf Half Y | 37.56% |
| Sales | 1.95B | P/B | 2.47 | EPS next 5Y | 5.99% | ROA | 8.26% | Short Interest | 4.82M | Perf YTD | 25.15% |
| Book/sh | 10.85 | P/C | 5.38 | EPS past 3/5Y | 34.98% - | ROE | 20.39% | 52W High | -4.19% ($27.94) | Perf Year | 57.38% |
| Cash/sh | 4.97 | P/FCF | 9.51 | Sales past 3/5Y | -0.99% 1.99% | ROIC | 13.42% | 52W Low | 70.56% ($15.69) | Perf 3Y | 109.8% |
| Dividend Est. | - | EV/EBITDA | 9.07 | EPS Y/Y TTM | 63.72% | Gross Margin | 25.05% | Volatility(W/M) | 2.79% 2.85% | Perf 5Y | -9.01% |
| Dividend TTM | - | EV/Sales | 1.23 | Sales Y/Y TTM | 0.51% | Oper. Margin | 12.34% | ATR (14) | 0.82 | Perf 10Y | -59.37% |
| Dividend Ex-Date | - | Quick Ratio | 1.32 | EPS Q/Q | 6.62% | Profit Margin | 8.96% | RSI (14) | 53.04 | Recom | 2.71 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.32 | Sales Q/Q | 4.04% | SMA20 | 0.36% ($26.67) | Beta | 0.6 | Target Price | $26.33 |
| Payout | - | Debt/Eq | 0.7 | Earnings | 2026/8/4 | SMA50 | 1.33% ($26.42) | Rel Volume | 0.65 | Prev Close | $26.73 |
| Employees | 6575 | LT Debt/Eq | 0.48 | EPS/Sales Surpr. | 6.6% 1.94% | SMA200 | 16.09% ($23.06) | Avg Volume(3M) | 0.79M | Price | $26.77 |
| IPO | 1995/9/20 | Option/Short | Yes/Yes | Trades | 5703 | Volume | 516,906 | Change | 0.15% |
Company
MD is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
👶 This is a US medical group that provides specialized healthcare services for newborns, expectant mothers, and pediatric patients. Backed by a team of specialist physicians, the company delivers care across neonatal intensive care, obstetrics and fetal medicine, and pediatric specialty services through partnerships with hospitals, and operates a nationwide network of medical specialists. It has established itself as a dedicated provider of specialized healthcare services focused on the newborn, maternal, and pediatric segments.
Over the past 1 year, on the higher side
4% below its 1-year high.
MD makes money exceptionally well
12.34% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +15.1% this year.
Tap to view numbers
The price looks about right
Trading at 12.9 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Would have changed by +109.8% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 104.3%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
ABLS 0.02%
XHS 0.02%
ASCE 0.02%
BSMC 0.02%
ECML 0.01%Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
AMDL 952M
AMDY 392M
AMDW 147M
AMUU 78M
AMDG 34MIt ranks #4 in the industry
Based on market cap of $2B.
MD $2B PER 12.9
HCA $92B PER 14.3
THC $21B PER 10.2
EHC $12B PER 19.8
FAQ
What kind of company is MD?
MD belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of MD?
The market cap of MD is approximately $2.2B, ranking 2,027 within its sector.
What is the P/E ratio of MD?
MD has a P/E ratio of approximately 12.9x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for MD?
MD has recorded a 52-week high of $27.94 and a low of $15.69.
